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Introduction
The past 20 years have seen the development of microneedles as an alternative to traditional subcutaneous needles for transdermal delivery of substances that are of medical interest. Microneedles have been used for the delivery of pharmacological compounds [1] and for vaccination [2, 3] . Research efforts have also been devoted to extend the use of microneedles beyond their traditional purpose of drug delivery, as it was the case in the use of metalized microneedles for electroporation therapy [4] .
Hollow microneedles applied onto the skin are able to extract interstitial fluid [5, 6] , offering a solution for a minimally invasive sensor of biomarkers in bodily fluids.
However, detection of biomarkers of interest is done off-line [7] , which requires the extraction of interstitial fluid from the body. Regardless of the method of extraction, the concept is hindered by the need of high vacuum pressures (200-500 mm Hg) for the extraction and collection of fluid [6] . Additionally, the volumes of fluid collected are variable [6, 8] and little is known of the reliability of extraction in a continuous basis. In conclusion, the complexity of a sensor able to provide continuous information of biochemical analytes in a physiological fluid would be drastically reduced with a design that did not require the uptake of biological fluids.
The use of electrochemical sensors can be a solution for an on-line detection without the need of sample extraction. Furthermore, miniaturised electrochemical sensors are more sensitive than macroscopic sensors [9] and electrochemical instrumentation is relatively easily miniaturised [10] . Recently, hollow polymeric microneedle arrays were filled with microelectrodes and used for the amperometric detection of hydrogen peroxide, lactate, glutamate and glucose [11, 12] .
We report here a novel sensor based on an array of hollow microneedles filled with an organogel able to sense ionic species in a physiological fluid. This platform takes advantage of the possibility to polarise the interface formed between the organogel, located inside the hollow microneedle, and the physiological fluid. Electrochemical sensors based on micro-interfaces between two immiscible electrolyte solutions (µITIES) have been developed in recent years [13, 14] . This electrochemical technique is based on ions transferring across a polarized liquid-gel interface upon application of a potential difference. Ion transfer from one phase to another gives rise to a current that can be monitored. Silicon-based micro and nano ITIES have been developed for the detection of analytes that are not redox active molecules [15, 16] .
Examples like detection of dopamine [17] and peptides [18, 19] show the potential of this technique as an alternative to traditional electrochemical techniques.
We propose the use of a novel diagnostic platform that combines a hollow microneedle array with electrochemical detection at µITIES. The presence of the µITIES in the inner bore of the microneedles offers several advantages: it avoids the need of fluid extraction, as the ions cross the gel-liquid interface due to the potential difference applied at the interface; additionally, the reduced dimensions of the interface enhance rapid diffusion of species, which improves detection limits of the analytes. This effect is illustrated in different works on µITIES [18] [19] [20] [21] and even used for the development of bioanalytical sensors [22] .
We have selected propranolol as a model analyte. This drug belongs to the βadrenergic blocking group [23] ; it reduces heart rate and blood pressure, which makes it useful for treatment of hypertension and chest pain related to heart failure (angina) [23] . Blood pressure and heart rate correlate with propranolol levels in plasma [24] . Therefore, its direct measure in a physiological matrix could be useful for correct drug dosage and the monitoring of patient response to treatment.
Propranolol has already been detected by ion transfer voltammetry at µITIES at concentration levels that are physiologically relevant [25] [26] [27] , thus allowing useful comparison with the results reported here.
We present also the characterisation of the silicon microneedle system by scanning electron microscopy (SEM) and cyclic voltammetry (CV) of tetraethyl ammonium (TEA + ). This model analyte has been used extensively in the characterization of ITIES, as it presents rapid and mechanistically simple transfers in these systems [28] [29] [30] [31] . The array is then used for the detection of propranolol in physiological medium by differential pulse stripping voltammetry (DPSV).
Material and methods

Reagents
All the reagents were purchased from Sigma-Aldrich Ireland Ltd. and used as received except for 1,6-dichlorohexane (1,6-DCH) (Merck), that was purified according to the published procedure [32] . The organic electrolyte salt was prepared by metathesis of bis-(triphenylphosphoranylidene) ammonium chloride (BTPPA + Cl -) and of potassium tetrakis(4-chlorophenyl)-borate (K + TPBCl -) to obtain BTPPATPBCl, following the published experimental procedure [33] . The organogel phase was prepared using purified 1,6-DCH and low molecular weight polyvinylchloride (PVC) 10:1 (v:w) [14] . For the experiments of propranolol detection at the µITIES array, the aqueous phase was composed of magnesium pyrophosphate (1.6 mg L -1 ), carboxymethyl cellulose (4 g L -1 ), urea (4 g L -1 ), disodium hydrogen phosphate (0.6 g L -1 ), anhydrous calcium chloride (0.6 g L -1 ), potassium chloride (0.4 g L -1 ), and sodium chloride (0.4 g L -1 ).
Microneedle array-µITIES
The silicon microneedle arrays were fabricated using a combination of potassium hydroxide (KOH) wet-etching and Bosch dry-etching techniques [34, 35] ; the final microneedle array is shown in the scanning electron micrograph of figure 1A . Briefly, square oxide/nitride masks were patterned using standard photolithography tools on a <100>, boron doped, 100 mm diameter monocrystalline silicon wafer. These masks are aligned with the <110> direction and the patterned silicon wafer is then etched in a 29 % w/v aqueous KOH solution. Convex corner mask undercut takes place, leading to the formation of two angled planes at each corner, which eventually intersect to form an octagonal microneedle. This needle is comprised of eight {263} planes, a base of {212} planes and has a height to base aspect ratio of 3:2.
To form hollow bores through the microneedles, a 3 µm Plasma-Enhanced Chemical Vapour Deposition (PECVD) oxide layer is deposited and patterned on the rear of the wafer to act as a hard mask; a 2 µm layer of aluminium is sputtered on the front side of the wafer to act as an etch stop layer. 50 µm diameter capillary conduits are then micromachined from the back side of the wafer using a Surface Technology System (STS) ASE ICP dry etching tool incorporating Bosch dry etching technology; the etch gases are SF6 and C4F8. Afterwards, the aluminium layer and thick oxide layers are stripped from the front and back sides of the wafer, respectively.
In the case of the array used, the 300 µm high microneedles were separated by 1 mm. The bore is of a cylindrical shape with a diameter comprised between 55 and 62 µm as it is shown on the scanning electron microscope (SEM) image of figure 1A. The creation of a micro ITIES at the microneedles is done by filling their bores with the organogel. A glass cylinder of 9 mm of inner diameter was sealed to the back of the microneedle array with silicone rubber. This configuration encloses a total of 52 hollow microneedles available for the experiments. The fabricated needles feature hydrophobic walls, which allowed an easy filling of the microneedle holes with the organogel; the latter had been heated gently at 50 °C in order to reduce its viscosity.
The filling was done by pipetting the organogel onto the back of the microneedle array. Once the holes were filled (see figure 1B) , the array was left to rest for at least 1 h before proceeding with the experiments.
Electrochemical set-up
In order to perform the electrochemical measurements, the system was configured as shown in figure 2. For all experiments, the electrodes were connected to a CHI660B electrochemical analyser (CH Instruments, Texas, purchased from IJ Cambria, Burry Port, Wales, United Kingdom). Cyclic voltammetry was used as characterisation method, and differential pulse stripping voltammetry (DPSV) was chosen as the analytical detection method. The stripping method consisted of three steps: (i) preconditioning, (ii) preconcentration and (iii) detection. First, the ITIES went through an optimised preconditioning step during which a potential of 0.45 V was maintained for 120 s to clean the gel from any residuals of the analyte that may remain from a previous experiment. A preconcentration step was then used to transfer the analyte from the aqueous phase to the organic phase; the potential was held at 0.86 V for a period between 15 and 240 s to transfer the analytes to the organogel. These two steps allow concentrating the propranolol in the organogel. Finally, the detection step consisted of the back transfer of the preconcentrated propranolol to the aqueous phase by the scanning of a predefined potential window. The parameters for DPSV were: amplitude = 80 mV; pulse width = 0.1 s; sample width = 0.05 s; pulse period = 0.2 s. This DPSV protocol has been described previously [25] .
Results and discussion
System characterization by cyclic voltammetry analysis
The electrochemical response of the hollow microneedle system was characterized by ion transfer voltammetry of the model analyte tetraethyl ammonium cation (TEA + ) at the ITIES formed in the bore of the needles. Before proceeding with any experiments, we determined the optimal scan rate values for the geometry of the needle array. The diffusion layer thickness (δ) should ideally be larger than the µITIES formed in the microneedles bores but not as large as to cause adjacent diffusion layers to overlap. This condition is highly desired as it results in the maximum faradaic current to background current ratio. To ensure non-overlapping diffusion areas between the holes of the array, it is sufficient to have > 2 [36] , d being the distance of the holes from centre to centre.
The diffusion area can be approximated by Einstein's equation for the root meansquare displacement of diffusing particles with Brownian motions:
In eq. (1), D is the diffusion coefficient (m 2 s -1 ); ΔE is the difference of potential between the onset of electrolysis and the peak of limiting current (V);  is the scan rate (V s -1 ). The substitution of this expression in the aforementioned condition for independent diffusion layers leads to the following equation for the scan rate:
In the particular case of our experiments, eq. (2) gives  = 2.35 mV s -1 as the lower limit that present radial diffusion with no overlapping areas (taking D = 9.8·10 -6 cm 2 s -1 for TEA + and ΔE = 0.3 V). All the experimental work was carried out with  values higher than this limit. Therefore, the distance between adjacent microneedles (20 times the radius of the inner needle bore) is sufficiently large to avoid overlapping of the diffusion layer. Figure 3A shows the cyclic voltammogram in the absence and in the presence of TEA + in the aqueous phase. In the absence of TEA + , the potential window is limited by the transfer of the background electrolytes, noticeable in the steep variations of current at potentials greater than + 0.9 V and lower than + 0.2 V. The capacitance at + 0.6 V was estimated to be of (16.46 ± 0.40) µF cm -2 .
With the experiments conditioned as by the above calculations, asymmetry in the CVs was expected, as it has already been observed in a number of µITIES systems [37] . In these reported cases, a sigmoidal wave is observed in the forward scan, which results from the radial diffusion of species in the aqueous phase. On the other hand, the reverse scan showed a peak that corresponded to the linear diffusion of species inside the pores.
According to this, the microneedle system should present a steady state response during the forward sweep in the form of a sigmoidal curve for the TEA + transfer.
However, as shown in figure 3A , it is hard to distinguish the TEA + transfer from the background electrolyte transfer. This could be explained by the hindered diffusion towards the interface. The bore of the microneedle is not centred but slightly shifted to the side as it is shown in figure 1A and schematically represented in figure 3B . As a consequence, diffusion of species towards the micro-interface is not hemispherical as it can be observed at regular disk micro-interfaces. It presents a diffusion profile mixed between radial and linear as represented by the arrows in figure 3B. By contrast, the reverse sweep presents a peak-shaped voltammogram indicating a diffusion-controlled return of the analyte from the organic to the aqueous phase (see again figure 3 ). This was further corroborated by subsequent experiments where the scan rate was varied between 5 and 17 mV s -1 (see figure 4 ). The measured reverse peak current is directly proportional (with R 2 =0.997) to the square root of the scan rate, which confirms the presence of the diffusion-controlled process when TEA + transfers back to the aqueous phase. The gel phase forms a recessed interface at the aqueous side of the ITIES (as it can be seen in figure1B). Computational simulations have shown that this configuration is optimal for stripping voltammetry, as transport of analyte species to the gel microinterface improves with a hemispherical diffusion regime during the preconcentration step [38] . Once they are transferred to the organic phase, they remain in the vicinity of the interface because of the reduced mass transport caused by both the linear diffusion and the lower diffusion coefficient in the PVC gel. Simulation studies have shown that the diffusion coefficient of TEA + was estimated to be nine times lower in the gel phase than in the aqueous solution [39] . The CV behaviour allows us to use eq. (3) to calculate the radius of the microneedle bore based on the propranolol limiting current, ilim, measured on the forward scan. The use of differential pulse stripping voltammetry (DPSV) as the analytical technique offers the possibility to detect lower concentrations of the analyte as capacitive/background current is eliminated. Figure 6 shows the DPSVs for increasing preconcentration times ranging from 15 to 240 s. Stripping peak currents increase slowly with the preconcentration time.
Voltammetric detection of propranolol at the microneedle array
Noticeably, the stripping peak current after 240 s of preconcentration is approximately 5 times higher than the one measured for 15 s. Based on these results, a preconcentration time t = 240 s was selected for the rest of experiments, as it provided the maximum current peak that was recorded. the stripping peak currents present a saturation effect. This could be justified by the fact that diffusion of propranolol is reduced due to the viscosity of the gel. The lowest concentration that the system was able to detect was 50 nM, which is within the detection limits published for propranolol [25, [43] [44] [45] [46] .
Conclusions
This report presents for the first time the development of a microneedle array with an embedded µITIES platform that is electrochemically able to detect propranolol.
Although there is a wealth of literature reporting the use of µITIES for electrochemical detection, previous works were based in the use of micropipettes or arrays of micro and nano-holes as support structures for the miniaturized ITIES.
The array of sensors was capable of detecting propranolol in artificial saliva with good sensitivity and a limit of detection that is of pharmacological relevance. The use of miniaturized interfaces and DPSV as the analytical method of detection deliver a low limit of detection, 50 nM, which compares well with previously published results for propranolol. This includes 0.2 μM with adsorptive stripping differential pulse voltammetry [47] ; 5 μM for potentiometric membrane electrode [45] ; 0.02 μM with cathodic adsorptive stripping voltammetry [48] ; 0.1 μM for capillary electrophoresis [49] . The platform presents a linear range between 50 and 200 nM.
Our future line of work will address the application of the microneedle-µITIES system to the detection of biomarkers for in vivo applications. The characteristics of the microneedle-ITIES could be beneficial in a scenario for transdermal analysis, as the system can overcome the skin barrier with minimal pain (thanks to the microneedles) and without physiological fluid extraction (due to the µITIES embedded).
Nevertheless, the chemicals used for the organogel are toxic and will not be used as such for in-vivo applications. Future developments will need the investigation of new materials for the organic phase. We will look into compounds that present both biocompatibility and stability in the long term (the organogel presently used is volatile at air atmosphere and degrades slowly with time).
Additionally, even though the presence of the organogel in the bore of the needles should avoid potential clogging in transdermal applications, we will study this issue during future experimental work. from light green to black, respectively). The experiments correspond to an array of needles with 56 micropores.
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(Inset) Reverse current peaks against square root of . The peaks present a linear slope with the square root of , which is a typical response of diffusion-prevailing systems (R 2 =0.997). 
